(Reuters) -GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory syncytial virus (RSV) and shingles vaccines in the third quarter, ...

(Reuters) -GSK (GSK) on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory syncytial virus (RSV) and shingles vaccines in the third ...

Arexvy sales slumped 72% to 188 million pounds ($244.40 million) in the quarter ended Sept. 30, missing market expectations of 238 million pounds, while sales of shingles vaccine, Shingrix, fell 7 ...

(Reuters) – GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory syncytial virus (RSV) and shingles vaccines in the third quarter, ...

Finally, it’s too late for your mother, but older people who have not had the newer two-dose shingles vaccine (Shingrix) should get it, even if they had the old one-dose vaccine (Zostavax ...

On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer/BioNTech and Moderna, for ages 6 months and up. About a week later ...

and the adjuvanted recombinant herpes zoster (shingles) vaccine (RSV) with that of simultaneous administration of the RZV and quadrivalent high-dose inactivated nonadjuvanted flu vaccine (HD-IIV4) ...

Cohen's research is waiting for peer review and publication. There is a vaccine for shingles that's more than 90% effective but only about a quarter of eligible adults get it. "I'm hoping that we ...

The HZV vaccine is given to adults 50 and older who are at a high risk of shingles. There is only one shingles vaccine available in the United States, called Shingrix. Since the pandemic began, the ...